Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Sargentini-Maier, Maria Laura
21  Ergebnisse:
Personensuche X
?
1

Reproducibility Study on a PBPK Model of FcRn-Mediated Recy..:

Sargentini-Maier, Maria Laura ; Van Bogaert, Tom ; Avery, Lindsay B....
Physiome.  , 2024
Link: https://doi.org/10.36903..
 
?
2

Reproducibility Study on a PBPK Model of FcRn-Mediated Recy..:

Sargentini-Maier, Maria Laura ; Van Bogaert, Tom ; Avery, Lindsay B....
Physiome.  , 2024
Link: https://doi.org/10.36903..
 
?
3

Reproducibility Study on a PBPK Model of FcRn-Mediated Recy..:

Sargentini-Maier, Maria Laura ; Van Bogaert, Tom ; Avery, Lindsay B....
Physiome.  , 2024
Link: https://doi.org/10.36903..
 
?
4

Reproducibility Study on a PBPK Model of FcRn-Mediated Recy..:

Sargentini-Maier, Maria Laura ; Van Bogaert, Tom ; Avery, Lindsay B....
Physiome.  , 2024
Link: https://doi.org/10.36903..
 
?
5

Reproducibility Study on a PBPK Model of FcRn-Mediated Recy..:

Sargentini-Maier, Maria Laura ; Van Bogaert, Tom ; Avery, Lindsay B....
Physiome.  , 2024
Link: https://doi.org/10.36903..
 
?
6

Reproducibility Study on a PBPK Model of FcRn-Mediated Recy..:

Sargentini-Maier, Maria Laura ; Van Bogaert, Tom ; Avery, Lindsay B....
Physiome.  , 2024
Link: https://doi.org/10.36903..
 
?
7

Mechanistic incorporation of FcRn binding in plasma and end..:

de Witte, Wilhelmus E. A. ; Avery, Lindsay B. ; Mackness, Brian C....
Journal of Pharmacokinetics and Pharmacodynamics.  50 (2023)  3 - p. 229-241 , 2023
Link: https://doi.org/10.1007/..
 
?
8

Clinical pharmacology of caplacizumab for the treatment of ..:

Sargentini-Maier, Maria Laura ; De Decker, Philip ; Tersteeg, Claudia...
Expert Review of Clinical Pharmacology.  12 (2019)  6 - p. 537-545 , 2019
Link: https://doi.org/10.1080/..
 
?
9

Assessment of levetiracetam bioavailability from targeted s..:

Stockis, Armel ; Sargentini-Maier, Maria Laura ; Otoul, Christian...
Clinical Therapeutics.  32 (2010)  10 - p. 1813-1821 , 2010
Link: https://doi.org/10.1016/..
 
?
10

Pharmacokinetics of levetiracetam XR 500mg tablets:

Rouits, Elisabeth ; Burton, Ingrid ; Guénolé, Evelyne...
Epilepsy Research.  84 (2009)  2-3 - p. 224-231 , 2009
Link: https://doi.org/10.1016/..
 
?
11

Retrospective Population Pharmacokinetic Analysis of Leveti..:

Toublanc, Nathalie ; Sargentini-Maier, Maria Laura ; Lacroix, Brigitte..
Clinical Pharmacokinetics.  47 (2008)  5 - p. 333-341 , 2008
Link: https://doi.org/10.2165/..
 
?
12

Corrigendum to "Modeling and simulation of intravenous leve..:

Snoeck, Eric ; Jacqmin, Philippe ; Sargentini-Maier, Maria Laura.
Epilepsy Research.  78 (2008)  2-3 - p. 246 , 2008
Link: https://doi.org/10.1016/..
 
?
13

Modeling and simulation of intravenous levetiracetam pharma..:

Snoeck, Eric ; Jacqmin, Philippe ; Sargentini-Maier, Maria Laura.
Epilepsy Research.  76 (2007)  2-3 - p. 140-147 , 2007
Link: https://doi.org/10.1016/..
 
?
14

Population Pharmacokinetics of??Levetiracetam in Japanese a..:

Pigeolet, Etienne ; Jacqmin, Philippe ; Sargentini-Maier, Maria-Laura.
Clinical Pharmacokinetics.  46 (2007)  6 - p. 503-512 , 2007
Link: https://doi.org/10.2165/..
 
?
15

The pharmacokinetics, CNS pharmacodynamics and adverse even..:

Rolan, Paul ; Sargentini-Maier, Maria Laura ; Pigeolet, Etienne.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2485265.  , 2008
Link: http://www.ncbi.nlm.nih...
 
1-15